Pfizer CEO Albert Bourla speaks shakes hands with U.S. President Donald Trump in a White House event on Tuesday. Getty Images

P resident Trump and Pfizer announced a deal to cut drug pricing yeseterday. And it looks like the pharmaceutical giant got the better end of it. Signed at a showy news conference on Tuesday, the agreement gives CEO Albert Bourla and his company a reprieve from threatened tariffs and something of a truce from an Administration that he had been battling. It was a win so clear that the company’s shares have risen about 16% since its announcement.

The price of that stability, from Pfizer’s perspective, isn’t very much– a fraction of its revenue and one that isn’t expected to have much impact on its bottom line. “It’s worth noting that Pfizer’s news release didn

See Full Page